ScholarIQanswers from OpenAlex

Abstract No. 509 Oncolytic immunotherapy of hepatic tumors with intralesional rose bengal disodium

PaperCitations, authors & open-access status

Abstract No. 509 Oncolytic immunotherapy of hepatic tumors with intralesional rose bengal disodium is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Abstract No. 509 Oncolytic immunotherapy of hepatic tumors with intralesional rose bengal disodium have?

ScholarIQcitation count

Abstract No. 509 Oncolytic immunotherapy of hepatic tumors with intralesional rose bengal disodium has 0 citations in the OpenAlex counts ScholarIQ stores.

When was Abstract No. 509 Oncolytic immunotherapy of hepatic tumors with intralesional rose bengal disodium published?

ScholarIQyear

Abstract No. 509 Oncolytic immunotherapy of hepatic tumors with intralesional rose bengal disodium has 2020 year in the ScholarIQ index.

What is the open-access status of Abstract No. 509 Oncolytic immunotherapy of hepatic tumors with intralesional rose bengal disodium?

ScholarIQoa status

Abstract No. 509 Oncolytic immunotherapy of hepatic tumors with intralesional rose bengal disodium has bronze oa status in the ScholarIQ index.

What is the DOI of Abstract No. 509 Oncolytic immunotherapy of hepatic tumors with intralesional rose bengal disodium?

ScholarIQdoi

The DOI for Abstract No. 509 Oncolytic immunotherapy of hepatic tumors with intralesional rose bengal disodium is on the source record.

What is the OpenAlex record for Abstract No. 509 Oncolytic immunotherapy of hepatic tumors with intralesional rose bengal disodium?

ScholarIQopenalex

The OpenAlex for Abstract No. 509 Oncolytic immunotherapy of hepatic tumors with intralesional rose bengal disodium is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial